Netanya, Israel

Eti Kovalevski-Ishai

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2004-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eti Kovalevski-Ishai. Retrieved from https://idiyas.com/inventor/eti-kovalevski-ishai-j2qa4lov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 35(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of Eti Kovalevski-Ishai

Introduction: Eti Kovalevski-Ishai, a pioneering inventor hailing from Netanya, Israel, is known for her groundbreaking contributions to the field of technology and innovation.

Latest Patents: Eti Kovalevski-Ishai's recent patents include advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge medical devices for remote patient monitoring.

Career Highlights: With a career spanning over two decades, Eti Kovalevski-Ishai has held key roles in leading tech companies, driving innovation and spearheading research and development projects that have revolutionized various industries.

Collaborations: Eti Kovalevski-Ishai has collaborated with top research institutions and universities worldwide, fostering a culture of innovation and knowledge-sharing to push the boundaries of technological advancements.

Conclusion: Eti Kovalevski-Ishai's relentless pursuit of innovation and her passion for creating solutions that positively impact society solidify her as a trailblazer in the world of inventions and patents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…